Mylan Inc (NASDAQ:MYL)

Data as of Oct 17
 +0.69 / +1.41%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Generic

Company Description

Mylan, Inc. is a generic and specialty pharmaceuticals company, through its subsidiaries, which develops, manufactures, markets and distributes pharmaceuticals. The company operates its business through two segments: Generics & Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. Mylan was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA.

Contact Information

Mylan, Inc.
1500 Corporate Drive
Canonsburg Pennsylvania 15317
P:(724) 514-1800
Investor Relations:



Other institutional51.65%
Mutual fund holders38.33%
Individual stakeholders2.55%

Top Executives

Heather M. BreschChief Executive Officer & Director
Rajiv MalikPresident & Director
John D. SheehanChief Financial Officer & Executive Vice President
Daniel C. RizzoSenior Vice President & Controller
Joseph F. HaggertySecretary, Senior VP & Global General Counsel

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.